Durable Complete Response in a Patient With BRAF-Mutated Advanced Melanoma With Ocular and Skin Toxicities from BRAF MEK Targeted Therapy After Immune Checkpoint Inhibitor Treatment: A Case Report. Dermatol Reports 2025. https://doi.org/10.4081/dr.2025.10324.